Title:
【発明の名称】いかなる感染(特にHIVを含むSTD)、炎症、腫瘍、またはいかなる他の粘膜及び/または皮膚の疾患を予防及び/または治療するための方法及び処方
Document Type and Number:
Japanese Patent JP2000510836
Kind Code:
A
Abstract:
PCT No. PCT/CA97/00319 Sec. 371 Date Jan. 13, 1999 Sec. 102(e) Date Jan. 13, 1999 PCT Filed May 9, 1997 PCT Pub. No. WO97/42962 PCT Pub. Date Nov. 20, 1997This invention relates to formulations comprising film-forming components capable of forming per se a physical barrier to pathogens. Thermoreversible gels such as poloxamers are particularly preferred for that use. The film-forming formulations may further comprise microbicides, spermicides or any other drug, which choice is guided by the pathogen, organism or the disease to be inactivated or treated. The formulations are therefore efficient as a physical, and optionally, as a chemical or pharmacological barrier as well as usable as a sustained drug-release system at the locus of administration. A part of the drug may also be entrapped in liposomes or other drug carriers. These formulations are intended for use in the prevention of sexually transmitted diseases, as well as in the treatment of infections, cancer, inflammation or any disease or state which requires a pharmacological treatment. Formulations are applicable to mucosae, skin and eye, for example.
Inventors:
Michelle Gee, Bergeron
De Solmo, Andre
Michele Tlambre
De Solmo, Andre
Michele Tlambre
Application Number:
JP54033897A
Publication Date:
August 22, 2000
Filing Date:
May 09, 1997
Export Citation:
Assignee:
Michelle Gee, Bergeron
De Solmo, Andre
Michele Tlambre
De Solmo, Andre
Michele Tlambre
International Classes:
A61K9/00; A61K31/00; A61K31/09; A61K31/14; A61K31/52; A61K31/522; A61K31/66; A61K31/662; A61K31/70; A61K31/765; A61K45/00; A61K45/06; A61K47/10; A61K9/127; A61K47/32; A61P17/00; A61P29/00; A61P31/00; A61P31/04; A61P35/00; (IPC1-7): A61K31/765; A61K9/127; A61P17/00; A61P29/00; A61P31/04; A61P35/00; A61K31/09; A61K31/14; A61K31/522; A61K31/662; A61K31/70; A61K45/00; A61K47/32
Attorney, Agent or Firm:
Masatake Shiga (1 person outside)